GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » E10

GSK (BUE:GSK) E10 : ARS1,036.27 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is GSK E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GSK's adjusted earnings per share data for the three months ended in Mar. 2024 was ARS135.956. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ARS1,036.27 for the trailing ten years ended in Mar. 2024.

During the past 12 months, GSK's average E10 Growth Rate was -2.60% per year. During the past 3 years, the average E10 Growth Rate was 8.60% per year. During the past 5 years, the average E10 Growth Rate was 7.70% per year. During the past 10 years, the average E10 Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of GSK was 12.20% per year. The lowest was -5.40% per year. And the median was 3.35% per year.

As of today (2024-05-17), GSK's current stock price is ARS12351.50. GSK's E10 for the quarter that ended in Mar. 2024 was ARS1,036.27. GSK's Shiller PE Ratio of today is 11.92.

During the past 13 years, the highest Shiller PE Ratio of GSK was 17.38. The lowest was 8.44. And the median was 12.92.


GSK E10 Historical Data

The historical data trend for GSK's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK E10 Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.96 143.88 202.78 311.43 937.84

GSK Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 387.96 513.00 789.10 937.84 1,036.27

Competitive Comparison of GSK's E10

For the Drug Manufacturers - General subindustry, GSK's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Shiller PE Ratio falls into.



GSK E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GSK's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=135.956/131.6000*131.6000
=135.956

Current CPI (Mar. 2024) = 131.6000.

GSK Quarterly Data

per share eps CPI Adj_EPS
201406 1.151 99.800 1.518
201409 0.703 100.000 0.925
201412 1.781 99.900 2.346
201503 13.711 99.600 18.116
201506 0.274 100.100 0.360
201509 0.991 100.200 1.302
201512 -0.884 100.400 -1.159
201603 0.754 100.400 0.988
201606 -1.117 101.000 -1.455
201609 2.021 101.500 2.620
201612 0.643 102.200 0.828
201703 2.534 102.700 3.247
201706 -0.488 103.500 -0.620
201709 3.592 104.300 4.532
201712 -1.792 105.000 -2.246
201803 1.952 105.100 2.444
201806 1.845 105.900 2.293
201809 8.568 106.600 10.577
201812 7.278 107.100 8.943
201903 5.376 107.000 6.612
201906 6.831 107.900 8.331
201909 13.410 108.400 16.280
201912 12.681 108.500 15.381
202003 14.980 108.600 18.153
202006 24.098 108.800 29.148
202009 14.846 109.200 17.891
202012 9.161 109.400 11.020
202103 16.632 109.700 19.952
202106 22.919 111.400 27.075
202109 19.341 112.400 22.645
202112 12.338 114.700 14.156
202203 31.405 116.500 35.476
202206 12.211 120.500 13.336
202209 208.268 122.300 224.105
202212 37.267 125.300 39.141
202303 43.753 126.800 45.409
202306 48.121 129.400 48.939
202309 77.093 130.100 77.982
202312 19.421 130.500 19.585
202403 135.956 131.600 135.956

Add all the adjusted EPS together and divide 10 will get our e10.


GSK  (BUE:GSK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GSK's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=12351.50/1036.27
=11.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of GSK was 17.38. The lowest was 8.44. And the median was 12.92.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


GSK E10 Related Terms

Thank you for viewing the detailed overview of GSK's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (BUE:GSK) Business Description

Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (BUE:GSK) Headlines

From GuruFocus

Kahn Brothers Buys 1, Sells 4 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-15-2023

Ridgewood Investments LLC Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-20-2023

Top 5 3rd Quarter Trades of Parallax Volatility Advisers, L.P.

By GuruFocus Research GuruFocus Editor 11-22-2022